tidytlg
A tables-listings-graphs package that reached CRAN and then went quiet.
A side-by-side editorial comparison of DoseFinding and serofoi — release velocity, themes, recent moves, and the top alternatives to consider.
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
serofoi grew a serosurvey simulator alongside the force-of-infection models it was built to fit.
serofoi estimates the force of infection from serological survey data using Bayesian serocatalytic models fitted through Stan. Beyond fitting it now simulates serosurveys — specifying a model and a survey design and generating the data such a survey would produce. The most recent release is visualisation and naming work.
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
serofoi estimates the force of infection from serological survey data using Bayesian serocatalytic models fitted through Stan. Beyond fitting it now simulates serosurveys — specifying a model and a survey design and generating the data such a survey would produce. The most recent release is visualisation and naming work.
The package moved from fitting-only to a fit-and-simulate pair. 0.1.0 added simulation from time- or age-varying force-of-infection trends and simplified the fitted object down to a Stan fit; 1.0.2 broadened simulation into full serosurvey generation with its own vignette. 1.0.3 then spent its effort on naming consistency and plotting options, which is what a package does once its scope is set.
With simulation and fitting both in place, the natural next step is tooling that closes the loop between them — recovery checks or study-design guidance built on simulated surveys.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or serofoi.
A tables-listings-graphs package that reached CRAN and then went quiet.
Tplyr made clinical summary tables explain where every number came from.
Clinical listings that keep inheriting their hardest problem — pagination — from the layer below.
A cache-directory helper that has shipped nothing but CRAN-triggered patches for seven years.
gigs redesigned its whole conversion API for rOpenSci, then spent three releases getting the docs to build.
A weather-data client that keeps rewriting its HTTP layer while slowly tightening its API.
See all DoseFinding alternatives → · See all serofoi alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. DoseFinding and serofoi are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DoseFinding and serofoi are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.
Top serofoi alternatives in Analytics are ranked by recent ship velocity. Browse the "serofoi alternatives" section above for the current picks, or visit /alternatives/serofoi for the full list with editorial commentary on each.